375 related articles for article (PubMed ID: 17440978)
1. A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention deficit hyperactivity disorder.
Yang B; Chan RC; Jing J; Li T; Sham P; Chen RY
Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):541-50. PubMed ID: 17440978
[TBL] [Abstract][Full Text] [Related]
2. Association study and a systematic meta-analysis of the VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder.
Grünblatt E; Werling AM; Roth A; Romanos M; Walitza S
J Neural Transm (Vienna); 2019 Apr; 126(4):517-529. PubMed ID: 30923918
[TBL] [Abstract][Full Text] [Related]
3. DAT1 3'-UTR 9R allele: preferential transmission in Indian children with attention deficit hyperactivity disorder.
Das M; Mukhopadhyay K
Am J Med Genet B Neuropsychiatr Genet; 2007 Sep; 144B(6):826-9. PubMed ID: 17440935
[TBL] [Abstract][Full Text] [Related]
4. The VNTR polymorphism in the human dopamine transporter gene: improved detection and absence of association of VNTR alleles with attention-deficit hyperactivity disorder.
Simsek M; Al-Sharbati M; Al-Adawi S; Lawatia K
Genet Test; 2006; 10(1):31-4. PubMed ID: 16545000
[TBL] [Abstract][Full Text] [Related]
5. [Association studies of dopamine D4 receptor gene and dopamine transporter gene polymorphisms in Han Chinese patients with attention deficit hyperactivity disorder].
Qian Q; Wang Y; Li J; Yang L; Wang B; Zhou R
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):412-8. PubMed ID: 12947560
[TBL] [Abstract][Full Text] [Related]
6. Sequence variation in the 3'-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD).
Feng Y; Wigg KG; Makkar R; Ickowicz A; Pathare T; Tannock R; Roberts W; Malone M; Kennedy JL; Schachar R; Barr CL
Am J Med Genet B Neuropsychiatr Genet; 2005 Nov; 139B(1):1-6. PubMed ID: 16082693
[TBL] [Abstract][Full Text] [Related]
7. Evidence of an association between 10/10 genotype of DAT1 and endophenotypes of attention deficit/hyperactivity disorder.
Agudelo JA; Gálvez JM; Fonseca DJ; Mateus HE; Talero-Gutiérrez C; Velez-Van-Meerbeke A
Neurologia; 2015 Apr; 30(3):137-43. PubMed ID: 24461309
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between the dopamine transporter gene 3' VNTR polymorphism and attention deficit hyperactivity disorder in Chinese Han children: case-control and family-based studies.
Wang Y; Wang Z; Yao K; Tanaka K; Yang Y; Shirakawa O; Maeda K
Kobe J Med Sci; 2008 Feb; 53(6):327-33. PubMed ID: 18762727
[TBL] [Abstract][Full Text] [Related]
9. Association of the DAT1 polymorphism with attention deficit hyperactivity disorder (ADHD): a family-based approach.
Lim MH; Kim HW; Paik KC; Cho SC; Yoon DY; Lee HJ
Am J Med Genet B Neuropsychiatr Genet; 2006 Apr; 141B(3):309-11. PubMed ID: 16526026
[TBL] [Abstract][Full Text] [Related]
10. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder.
Barr CL; Xu C; Kroft J; Feng Y; Wigg K; Zai G; Tannock R; Schachar R; Malone M; Roberts W; Nöthen MM; Grünhage F; Vandenbergh DJ; Uhl G; Sunohara G; King N; Kennedy JL
Biol Psychiatry; 2001 Feb; 49(4):333-9. PubMed ID: 11239904
[TBL] [Abstract][Full Text] [Related]
11. A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism.
Šerý O; Paclt I; Drtílková I; Theiner P; Kopečková M; Zvolský P; Balcar VJ
Behav Brain Funct; 2015 Jun; 11():21. PubMed ID: 26058807
[TBL] [Abstract][Full Text] [Related]
12. Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples.
Curran S; Mill J; Tahir E; Kent L; Richards S; Gould A; Huckett L; Sharp J; Batten C; Fernando S; Ozbay F; Yazgan Y; Simonoff E; Thompson M; Taylor E; Asherson P
Mol Psychiatry; 2001 Jul; 6(4):425-8. PubMed ID: 11443527
[TBL] [Abstract][Full Text] [Related]
13. Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD.
Bellgrove MA; Barry E; Johnson KA; Cox M; Dáibhis A; Daly M; Hawi Z; Lambert D; Fitzgerald M; McNicholas F; Robertson IH; Gill M; Kirley A
Neuropsychopharmacology; 2008 Sep; 33(10):2536-45. PubMed ID: 18046306
[TBL] [Abstract][Full Text] [Related]
14. Family-based and case-control association studies of DRD4 and DAT1 polymorphisms in Chinese attention deficit hyperactivity disorder patients suggest long repeats contribute to genetic risk for the disorder.
Qian Q; Wang Y; Zhou R; Yang L; Faraone SV
Am J Med Genet B Neuropsychiatr Genet; 2004 Jul; 128B(1):84-9. PubMed ID: 15211638
[TBL] [Abstract][Full Text] [Related]
15. Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults.
de Azeredo LA; Rovaris DL; Mota NR; Polina ER; Marques FZ; Contini V; Vitola ES; Belmonte-de-Abreu P; Rohde LA; Grevet EH; Bau CH
Eur Arch Psychiatry Clin Neurosci; 2014 Aug; 264(5):401-8. PubMed ID: 24487615
[TBL] [Abstract][Full Text] [Related]
16. No association between VNTR polymorphisms of dopamine transporter gene and attention deficit hyperactivity disorder in Chinese children.
Cheuk DK; Li SY; Wong V
Am J Med Genet B Neuropsychiatr Genet; 2006 Mar; 141B(2):123-5. PubMed ID: 16402340
[TBL] [Abstract][Full Text] [Related]
17. An association between a dopamine transporter gene (SLC6A3) haplotype and ADHD symptom measures in nonclinical adults.
Tong JH; Cummins TD; Johnson BP; McKinley LA; Pickering HE; Fanning P; Stefanac NR; Newman DP; Hawi Z; Bellgrove MA
Am J Med Genet B Neuropsychiatr Genet; 2015 Mar; 168B(2):89-96. PubMed ID: 25656223
[TBL] [Abstract][Full Text] [Related]
18. Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects.
Spencer TJ; Biederman J; Faraone SV; Madras BK; Bonab AA; Dougherty DD; Batchelder H; Clarke A; Fischman AJ
Biol Psychiatry; 2013 Jul; 74(2):84-9. PubMed ID: 23273726
[TBL] [Abstract][Full Text] [Related]
19. Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.
Joober R; Grizenko N; Sengupta S; Amor LB; Schmitz N; Schwartz G; Karama S; Lageix P; Fathalli F; Torkaman-Zehi A; Ter Stepanian M
Neuropsychopharmacology; 2007 Jun; 32(6):1370-6. PubMed ID: 17063150
[TBL] [Abstract][Full Text] [Related]
20. Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD.
Franke B; Vasquez AA; Johansson S; Hoogman M; Romanos J; Boreatti-Hümmer A; Heine M; Jacob CP; Lesch KP; Casas M; Ribasés M; Bosch R; Sánchez-Mora C; Gómez-Barros N; Fernàndez-Castillo N; Bayés M; Halmøy A; Halleland H; Landaas ET; Fasmer OB; Knappskog PM; Heister AJ; Kiemeney LA; Kooij JJ; Boonstra AM; Kan CC; Asherson P; Faraone SV; Buitelaar JK; Haavik J; Cormand B; Ramos-Quiroga JA; Reif A
Neuropsychopharmacology; 2010 Feb; 35(3):656-64. PubMed ID: 19890261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
